IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

NICHOLAS LACIVITA

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1700451291
CMS profile
11431304
Location
BRANDON, MS

General Payments · PY2022–2024

$3,607.08

  • Reported across 113 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,859.38

55 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Psychiatry MS All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,859.38 55

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Teva Pharmaceuticals USA, Inc. $483.98 13
Alkermes, Inc. $355.75 7
Neurocrine BioSciences, Inc. $243.83 11
Janssen Pharmaceuticals, Inc $207.68 10
Otsuka America Pharmaceutical, Inc. $147.00 2
ABBVIE INC. $136.61 6
E.R. Squibb & Sons, L.L.C. $112.86 1
Vanda Pharmaceuticals Inc. $83.78 1
Lundbeck LLC $73.71 3
Axsome Therapeutics, Inc. $14.18 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2022 $602.29 22
PY2023 $1,145.41 36
PY2024 $1,859.38 55

Payment records · PY2024 (55)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $21.27 02/23/2024 Food and Beverage Undisputed 01/23/2026 1104126366 CMS
ABBVIE INC. $25.40 03/12/2024 Food and Beverage Undisputed 01/23/2026 1104126368 CMS
ABBVIE INC. $28.95 04/26/2024 Food and Beverage Undisputed 01/23/2026 1104126370 CMS
ABBVIE INC. $7.66 05/02/2024 Food and Beverage Undisputed 01/23/2026 1104126372 CMS
ABBVIE INC. $31.96 05/31/2024 Food and Beverage Undisputed 01/23/2026 1104126374 CMS
ABBVIE INC. $21.37 08/23/2024 Food and Beverage Undisputed 01/23/2026 1104126376 CMS
Alkermes, Inc. $23.58 01/26/2024 Food and Beverage Undisputed 01/23/2026 1120537681 CMS
Alkermes, Inc. $12.31 03/14/2024 Food and Beverage Undisputed 01/23/2026 1120537683 CMS
Alkermes, Inc. $118.26 03/19/2024 Food and Beverage Undisputed 01/23/2026 1120537685 CMS
Alkermes, Inc. $18.81 03/22/2024 Food and Beverage Undisputed 01/23/2026 1120537687 CMS
Alkermes, Inc. $29.58 06/28/2024 Food and Beverage Undisputed 01/23/2026 1120537689 CMS
Alkermes, Inc. $29.15 07/26/2024 Food and Beverage Undisputed 01/23/2026 1120537691 CMS
Alkermes, Inc. $124.06 10/24/2024 Food and Beverage Undisputed 01/23/2026 1120537693 CMS
Axsome Therapeutics, Inc. $14.18 06/04/2024 Food and Beverage Undisputed 01/23/2026 1148308530 CMS
E.R. Squibb & Sons, L.L.C. $112.86 12/11/2024 Food and Beverage Undisputed 01/23/2026 1101412509 CMS
Janssen Pharmaceuticals, Inc $22.58 01/08/2024 Food and Beverage Undisputed 01/23/2026 1078062990 CMS
Janssen Pharmaceuticals, Inc $21.71 02/11/2024 Food and Beverage Undisputed 01/23/2026 1078062978 CMS
Janssen Pharmaceuticals, Inc $21.50 03/08/2024 Food and Beverage Undisputed 01/23/2026 1078062964 CMS
Janssen Pharmaceuticals, Inc $19.47 03/18/2024 Food and Beverage Undisputed 01/23/2026 1078063020 CMS
Janssen Pharmaceuticals, Inc $12.71 03/19/2024 Food and Beverage Undisputed 01/23/2026 1078063000 CMS
Janssen Pharmaceuticals, Inc $25.50 04/10/2024 Food and Beverage Undisputed 01/23/2026 1078062980 CMS
Janssen Pharmaceuticals, Inc $22.85 05/22/2024 Food and Beverage Undisputed 01/23/2026 1078063026 CMS
Janssen Pharmaceuticals, Inc $16.62 06/19/2024 Food and Beverage Undisputed 01/23/2026 1078063036 CMS
Janssen Pharmaceuticals, Inc $22.94 07/17/2024 Food and Beverage Undisputed 01/23/2026 1078063066 CMS
Janssen Pharmaceuticals, Inc $21.80 12/10/2024 Food and Beverage Undisputed 01/23/2026 1078063046 CMS
Lundbeck LLC $34.34 02/09/2024 Food and Beverage Undisputed 01/23/2026 1145937304 CMS
Lundbeck LLC $16.76 03/29/2024 Food and Beverage Undisputed 01/23/2026 1145937306 CMS
Lundbeck LLC $22.61 11/02/2024 Food and Beverage Undisputed 01/23/2026 1145937308 CMS
Neurocrine Biosciences, Inc. $22.14 03/15/2024 Food and Beverage Undisputed 01/23/2026 1150850830 CMS
Neurocrine Biosciences, Inc. $24.07 04/19/2024 Food and Beverage Undisputed 01/23/2026 1150842746 CMS
Neurocrine Biosciences, Inc. $25.89 05/17/2024 Food and Beverage Undisputed 01/23/2026 1150837431 CMS
Neurocrine Biosciences, Inc. $17.55 05/23/2024 Food and Beverage Undisputed 01/23/2026 1150866983 CMS
Neurocrine Biosciences, Inc. $21.21 06/21/2024 Food and Beverage Undisputed 01/23/2026 1150853993 CMS
Neurocrine Biosciences, Inc. $25.89 07/19/2024 Food and Beverage Undisputed 01/23/2026 1150837457 CMS
Neurocrine Biosciences, Inc. $25.76 08/16/2024 Food and Beverage Undisputed 01/23/2026 1150837834 CMS
Neurocrine Biosciences, Inc. $20.28 09/20/2024 Food and Beverage Undisputed 01/23/2026 1150857789 CMS
Neurocrine Biosciences, Inc. $21.04 10/18/2024 Food and Beverage Undisputed 01/23/2026 1150854539 CMS
Neurocrine Biosciences, Inc. $21.38 11/15/2024 Food and Beverage Undisputed 01/23/2026 1150853487 CMS
Neurocrine Biosciences, Inc. $18.62 11/27/2024 Food and Beverage Undisputed 01/23/2026 1150863499 CMS
Otsuka America Pharmaceutical, Inc. $22.00 03/26/2024 Food and Beverage Undisputed 01/23/2026 1118926915 CMS
Otsuka America Pharmaceutical, Inc. $125.00 07/11/2024 Food and Beverage Undisputed 01/23/2026 1118926917 CMS
Teva Pharmaceuticals USA, Inc. $27.71 01/22/2024 Food and Beverage Undisputed 01/23/2026 1151655052 CMS
Teva Pharmaceuticals USA, Inc. $17.23 02/02/2024 Food and Beverage Undisputed 01/23/2026 1151655074 CMS
Teva Pharmaceuticals USA, Inc. $96.43 02/08/2024 Food and Beverage Undisputed 01/23/2026 1151655085 CMS
Teva Pharmaceuticals USA, Inc. $14.39 03/29/2024 Food and Beverage Undisputed 01/23/2026 1151655110 CMS
Teva Pharmaceuticals USA, Inc. $21.31 04/15/2024 Food and Beverage Undisputed 01/23/2026 1151655139 CMS
Teva Pharmaceuticals USA, Inc. $16.69 05/03/2024 Food and Beverage Undisputed 01/23/2026 1151655169 CMS
Teva Pharmaceuticals USA, Inc. $83.83 05/16/2024 Food and Beverage Undisputed 01/23/2026 1151655205 CMS
Teva Pharmaceuticals USA, Inc. $104.73 05/17/2024 Food and Beverage Undisputed 01/23/2026 1151655172 CMS
Teva Pharmaceuticals USA, Inc. $23.73 06/05/2024 Food and Beverage Undisputed 01/23/2026 1151655194 CMS
Teva Pharmaceuticals USA, Inc. $24.07 06/07/2024 Food and Beverage Undisputed 01/23/2026 1151655198 CMS
Teva Pharmaceuticals USA, Inc. $24.39 08/14/2024 Food and Beverage Undisputed 01/23/2026 1151655245 CMS
Teva Pharmaceuticals USA, Inc. $23.07 09/06/2024 Food and Beverage Undisputed 01/23/2026 1151655279 CMS
Teva Pharmaceuticals USA, Inc. $6.40 11/27/2024 Food and Beverage Undisputed 01/23/2026 1151655315 CMS
Vanda Pharmaceuticals Inc. $83.78 09/12/2024 Food and Beverage Undisputed 01/23/2026 1133909740 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.